ARCHIVES

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

This article is from The Cancer Letter archive.

Vol. 18 No. 12 | March 20, 1992

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

DRCCA Completes New Cancer control Research Guidelines

August 5, 1983

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

January 1, 1988